UK's NICE Recommends Novartis Pharmaceuticals UK Limited (NVS) Eye Drug Lucentis
8/27/2008 7:25:31 AM
More...
|
Novartis Pharmaceuticals UK Limited (NVS) Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
5/20/2008 7:24:30 AM
More...
|
Novartis Pharmaceuticals UK Limited (NVS)'s Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver
12/12/2007 7:00:35 AM
More...
|
Novartis Pharmaceuticals UK Limited (NVS) New License for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic Announced Today
9/13/2007 8:11:30 AM
More...
|
Galapagos Genomics NV Signs Research Collaboration Agreement With Novartis Pharmaceuticals UK Limited (NVS)
10/19/2005 5:09:25 PM
More...
|